10-K annual report · filed Feb 27, 2026

American Healthcare REIT, Inc. (AHR) FY2025 10-K Annual Report

Short answer

American Healthcare REIT, Inc. (AHR) filed its fiscal 2025 10-K annual report with the SEC on Feb 27, 2026. It reported revenue of $2.1B (+11.2% year over year) and net income of $70M.

  • Top risk flagged: Healthcare regulation risk: potential loss of tenants’ Medicare/Medicaid participation impacting rent payments under U.S. federal/state healthcare laws

FY2025 key financial metrics · XBRL

Revenue
$2.1B
+11.2% YoY
Net income
$70M
+284.6% YoY
Operating margin
19.8%
+0.5 pp YoY
EPS (diluted)
$0.42
+244.8% YoY
ROE
2.1%
+3.8 pp YoY
Operating cash flow
$294M
+67.2% YoY

Source: XBRL data from the American Healthcare REIT, Inc. (AHR) FY2025 10-K on SEC EDGAR. USD.

American Healthcare REIT, Inc. FY2025 10-K analysis

AI summary of each section, grounded in the filing text

Business Overview

  • Core business: Self-managed REIT owning and operating clinical healthcare real estate including senior housing, skilled nursing, outpatient medical, across US, UK, Isle of Man
  • New emphasis: Public offering in Feb 2024 raised $772.8M gross; NYSE listing under symbol "AHR" and consolidation of multiple common stock classes into one
  • Strategic shift: Greater focus on integrated senior health campuses (ISHC) and senior-housing operating properties (SHOP) utilizing the RIDEA structure for enhanced operational and tax efficiency
  • Quantitative highlight: Employee count approximately 121 as of December 31, 2025, with a significant capital raise via equity offering in 2024
  • Noteworthy fact: Stock conversion on August 5, 2024, automatically combined Class T and Class I shares into listed common stock, streamlining capital structure post-IPO

Management Discussion & Analysis

  • Revenue $2,260M, up 9.1% YoY from $2,070.7M, driven by ISHC resident fees increase of $144.1M and SHOP increase of $66.6M
  • ISHC margin impacted by inflation and acquisition growth; real estate revenue decreased $21.3M, reflecting less OM and triple-net lease revenue
  • Best segment ISHC with $1,763.9M resident fees; worst performing OM segment revenue declined from $134.7M to $126.1M
  • Raised $379.8M via 2024 ATM, $701.4M via 2025 ATM, and $447.1M in November 2025 offering; acquired $1.05B in properties and disposed $60.4M assets
  • Management cautious on inflation, labor costs, potential interest rate rise; expects rent and care fee increases to offset cost pressures

Risk Factors

  • Healthcare regulation risk: potential loss of tenants’ Medicare/Medicaid participation impacting rent payments under U.S. federal/state healthcare laws
  • Macroeconomic threat: portfolio concentrated in healthcare real estate with 45.3% managed by Trilogy Manager contributing 55.5% of NOI as of 12/31/2025
  • Operational vulnerability: reliance on Trilogy Manager for ISHC operations, risk from its financial, legal, or personnel difficulties could materially harm the company
  • Competitive risk: significant competition for senior housing and healthcare facility acquisitions, with competitors possibly having greater resources and lower capital costs
  • Financial risk: CEO Danny Prosky on medical leave timing unknown, interim CEO appointed, key-person dependency could materially affect management stability

Generated from the filing text; verify against the original. How to read a 10-K

Ask about this 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.